By Lisa Jenkins VanLuvanee, Ph.D. Per the US FDA, orphan drugs address rare diseases affecting fewer than 200,000 people in the United States. Developing these therapies presents challenges beyond typical drug development. The ...
BTD/Orphan
By Lisa Jenkins VanLuvanee, Ph.D. Per the US FDA, orphan drugs address rare diseases affecting fewer than 200,000 people in the United States. Developing these therapies presents challenges beyond typical drug development. The ...
gET sOCIAL